Opinions with Workers' Group members as rapporteur/co-rapporteur/rapporteur-general

  • Ongoing (updated on 27/02/2024) - Bureau decision date: 15/02/2024
    Sygnatura
    TEN/841-EESC
    Workers - GR II
    Austria
    Civil Society Organisations - GR III
    Austria
    Plenary session number
    592
    -
  • Ongoing (updated on 27/02/2024) - Bureau decision date: 18/01/2024
    Sygnatura
    SOC/797-EESC
    Workers - GR II
    France
    Civil Society Organisations - GR III
    Germany
  • Ongoing (updated on 27/02/2024) - Bureau decision date: 18/01/2024
    Sygnatura
    SOC/798-EESC
    Workers - GR II
    Spain
    Civil Society Organisations - GR III
    Lithuania
  • Ongoing (updated on 27/02/2024) - Bureau decision date: 12/12/2023
    Sygnatura
    SOC/790-EESC
    Workers - GR II
    Italy
    Civil Society Organisations - GR III
    Italy
    Plenary session number
    590
    -
  • Ongoing (updated on 27/02/2024) - Bureau decision date: 13/02/2024
    Sygnatura
    SOC/804-EESC
    Workers - GR II
    Germany
    Civil Society Organisations - GR III
    Bulgaria
    Plenary session number
    589
    -
  • Ongoing (updated on 27/02/2024) - Bureau decision date: 25/04/2023
    Sygnatura
    SOC/773-EESC
    Civil Society Organisations - GR III
    Germany
    Workers - GR II
    Spain
    Plenary session number
    587
    -
  • Ongoing (updated on 22/02/2024) - Bureau decision date: 12/12/2023
    Sygnatura
    SOC/789-EESC
    Workers - GR II
    Italy
  • Ongoing (updated on 21/02/2024) - Bureau decision date: 15/02/2024
    Sygnatura
    SOC/803-EESC
    Workers - GR II
    France
    Plenary session number
    592
    -
  • Ongoing (updated on 21/02/2024) - Bureau decision date: 15/02/2024
    Sygnatura
    SOC/802-EESC
    Workers - GR II
    Spain
    Plenary session number
    591
    -
  • Ongoing (updated on 20/02/2024) - Bureau decision date: 24/07/2023
    Sygnatura
    CCMI/219-EESC-2023
    Workers - GR II
    Romania
    (Italy
    EESC section opinion: A European Innovation Stress Test for an innovative and forward-looking industrial policy: the example of the pharmaceutical sector